$2.67
+0.100 (+3.89%)
At Close: Jun 23, 2026
GoodRx to Present Virtually at the 40th Annual J.P. Morgan Healthcare Conference
09:05pm, Tuesday, 04'th Jan 2022 Kwhen FinanceGoodrx Holdings Inc (GDRX) Co-CEO Trevor Bezdek Sold $4.5 million of Shares
03:15pm, Friday, 24'th Dec 2021 GuruFocus
Related Stocks: GDRX ,
Counterpoint Global Portfolio Buys Bill.com Holdings Inc, Affirm Holdings Inc, GoodRx Holdings ...
06:38am, Friday, 24'th Dec 2021 GuruFocus
Related Stocks: BILL , AFRM , GDRX , RBLX , CRCT , ZI , CZOO , MTTR , DNA , DSY , DUOL , APP , APPF , SMAR , TAL , BABA , SRNG , CACC ,
Morgan Stanley Institutional Fund Inc Buys GoodRx Holdings Inc, Affirm Holdings Inc, Cricut ...
06:38am, Friday, 24'th Dec 2021 GuruFocus
Related Stocks: CRCT , FSLY , APPN , BAB , SKLZ , CRM , GDRX , AFRM , ZG , SPOT , APP , DNA , AGL , SMAR , EQH , CACC , OKTA , APPF , ASC ,
GoodRx Holdings Inc. (GDRX) Is A Stock Worth Accumulating At Current Levels
04:00pm, Thursday, 23'rd Dec 2021 Stocks Register
GoodRx Holdings Inc. (NASDAQ:GDRX) concluded the trading at $34.99 on Wednesday, December 22 with a fall of -2.34% from its closing price on previous day. Taking a look at stock we notice that its last check on previous day was $35.83 with its price kept floating in the range of $34.90 and $35.82 on the GoodRx Holdings Inc. (GDRX) Is A Stock Worth Accumulating At Current Levels Read More »
Stephens Initiates Coverage on GoodRx (NASDAQ:GDRX)
08:42am, Thursday, 23'rd Dec 2021 Transcript Daily
Stock analysts at Stephens assumed coverage on shares of GoodRx (NASDAQ:GDRX) in a report issued on Tuesday, Analyst Price Targets reports. The firm set an overweight rating and a $45.00 price target on the stock. Stephens price target suggests a potential upside of 28.61% from the stocks current price. Several other brokerages also recently commented []
Kestra Advisory Services LLC Cuts Stock Position in GoodRx Holdings, Inc. (NASDAQ:GDRX)
09:20am, Wednesday, 22'nd Dec 2021 ETF Daily News
Kestra Advisory Services LLC cut its position in GoodRx Holdings, Inc. (NASDAQ:GDRX) by 6.3% during the third quarter, HoldingsChannel.com reports. The fund owned 6,389 shares of the companys stock after selling 433 shares during the period. Kestra Advisory Services LLCs holdings in GoodRx were worth $262,000 at the end of the most recent reporting period. [] The post Kestra Advisory Services LLC Cuts Stock Position in GoodRx Holdings, Inc. (NASDAQ:GDRX) appeared first on ETF Daily News .
GoodRx (NASDAQ:GDRX) Earns Overweight Rating from Analysts at Stephens
03:40pm, Tuesday, 21'st Dec 2021 Dakota Financial News
Equities researchers at Stephens initiated coverage on shares of GoodRx (NASDAQ:GDRX) in a research report issued on Tuesday, The Fly reports. The firm set an overweight rating and a $45.00 price target on the stock. Stephens price target would suggest a potential upside of 33.57% from the stocks current price. A number of other research []
MODV vs. GDRX: Which Stock Is the Better Value Option?
01:00pm, Monday, 20'th Dec 2021
MODV vs. GDRX: Which Stock Is the Better Value Option?
Insider Selling: GoodRx Holdings, Inc. (NASDAQ:GDRX) Major Shareholder Sells 99,135 Shares of Stock
11:06am, Monday, 20'th Dec 2021 Dakota Financial News
GoodRx Holdings, Inc. (NASDAQ:GDRX) major shareholder Abdiel Capital Management, Llc sold 99,135 shares of the firms stock in a transaction dated Wednesday, December 15th. The shares were sold at an average price of $35.97, for a total value of $3,565,885.95. The sale was disclosed in a legal filing with the SEC, which is available through []
GoodRx: Formidable Tech Company Taking On Underpenetrated Health Market
12:57pm, Sunday, 19'th Dec 2021 Seeking AlphaGoodRx: Formidable Tech Company Taking On Underpenetrated Health Market
07:57am, Sunday, 19'th Dec 2021
Shares of GoodRx have slipped 20% this year even despite strong growth and progress toward capturing a massive market opportunity. The company is well poised to excel in 2022 as doctor visits and phar
GoodRx (NASDAQ:GDRX) PT Raised to $41.00 at Morgan Stanley
07:14am, Sunday, 19'th Dec 2021 Transcript Daily
GoodRx (NASDAQ:GDRX) had its target price upped by equities research analysts at Morgan Stanley from $38.00 to $41.00 in a note issued to investors on Friday, Price Targets.com reports. The brokerage currently has an equal weight rating on the stock. Morgan Stanleys price objective would suggest a potential upside of 21.70% from the stocks previous []
Goodrx Holdings Inc (GDRX) Co-CEO Douglas Joseph Hirsch Sold $4.8 million of Shares
02:15am, Saturday, 18'th Dec 2021 GuruFocus
Related Stocks: GDRX ,
How Will GoodRx Holdings Inc. (NASDAQ: GDRX) Look After It Drops -74.99% From Its Highs?
04:30pm, Friday, 17'th Dec 2021 Marketing Sentinel
During the last session, GoodRx Holdings Inc. (NASDAQ:GDRX)’s traded shares were 1.87 million. At the end of the trading day, the stock’s price was $34.10, reflecting an intraday loss of -9.24% or -$3.47. The 52-week high for the GDRX share is $59.67, that puts it down -74.99 from that peak though still a striking 21.82% … How Will GoodRx Holdings Inc. (NASDAQ: GDRX) Look After It Drops -74.99% From Its Highs? Read More »
Sign In
Buy GDRX